Monitoring the use of antibiotics is relevant due to the public health impact of microbial resistance, adverse effects, and costs. We present data on the consumption of @entity7187 , @entity35995 , @entity22282 and @entity115 / @entity798 (AMC) between 2007 and 2010 in the in-and outpatient healthcare setting in 10 European countries provided by IMS Health. Antibiotics were classified according to the anatomical therapeutic chemical classification and consumption was expressed in defined @entity2794 ( @entity2794 ). We analysed the number of prescriptions by diagnostic codes between 2008 and 2010, based on the International Classification of Diseases, 10th revision (ICD-10). These ICD-10 codes were grouped into four main categories: @entity1729 , @entity281 , other @entity281 and other diagnoses. In 2010, the consumption of @entity7187 and @entity35995 ranged from 0.45 @entity2794 (Sweden) to 5.46 @entity2794 (Italy), and from 0.04 @entity2794 (Denmark) to 1.00 DID (Germany), respectively. Streptogramins were available in France, Germany, Italy, Norway, Spain and United Kingdom with a consumption of <0.001 DID exclusively in the hospital setting. The consumption of AMC ranged from <0.001 @entity2794 (Norway) to 11.67 @entity2794 (Spain). During the study period, the consumption of @entity7187 decreased, the consumption of AMC increased in most of European countries, and @entity35995 varied very slightly. @entity7187 and AMC were mainly prescribed for @entity1729 in all countries but United Kingdom, where most of the prescriptions were assigned to diagnostic codes not clearly related with an @entity281 . @entity35995 were prescribed for the @entity1729 and other @entity281 groups. There was a wide inter-country variability in the percentage of the prescriptions assigned to each of the diagnostic categories. The inter-country differences in the consumption of these antibiotics and their prescription by diagnostic categories point to an inappropriate use of antibiotics.

Sales of @entity7187 , @entity35995 , streptogramins, and @entity115 / XXXX in the in- and outpatient setting in 10 European countries, 2007-2010.

@entity115 :: ('MESH:D000658', 'Chemical') :: ['amoxicillin'] @entity798 :: ('MESH:D019818', 'Chemical') :: ['clavulanate'] @entity22282 :: ('MESH:D025361', 'Chemical') :: ['streptogramins'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infection', 'genitourinary infections', 'infections'] @entity7187 :: ('MESH:D018942', 'Chemical') :: ['Macrolides', 'macrolides'] @entity2794 :: ('MESH:D020773', 'Disease') :: ['daily doses/1000 inhabitants/day', 'DIDs'] @entity1729 :: ('MESH:D012141', 'Disease') :: ['respiratory infections'] @entity35995 :: ('MESH:D055231', 'Chemical') :: ['Lincosamides', 'lincosamides']
@entity798 :: (MESH:D019818,Chemical) :: ['clavulanate']
